TRB Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
TRB Wealth Management's VRTX Position: Q3 2026 in Review
TRB Wealth Management increased its Vertex Pharmaceuticals (VRTX) stake by 2.4% in Q3 2026, buying an estimated $8.7K and bringing the position to 728 shares worth $381K. The position accounts for 0.05% of the portfolio, ranked #179.
TRB Wealth Management first reported a position in VRTX in Q1 2026 and has held it in 3 quarters since. 1,798 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- TRB Wealth Management held 728 shares of Vertex Pharmaceuticals worth $381K as of Q3 2026.
- TRB Wealth Management bought 17 Vertex Pharmaceuticals shares in Q3 2026, an estimated $8.7K.
- Vertex Pharmaceuticals made up 0.05% of TRB Wealth Management's portfolio in Q3 2026, its #179 holding.
- TRB Wealth Management first reported a position in Vertex Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
- 1,798 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on TRB Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.